Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe.

Autor: Poljak M; Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia. Electronic address: mario.poljak@mf.uni-lj.si., Seme K; Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia., Maver PJ; Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia., Kocjan BJ; Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia., Cuschieri KS; Specialist Virology Centre, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom., Rogovskaya SI; Department of Obstetrics and Gynecology, Russian Medical Academy of Post-Graduate Education, Moscow, Russia., Arbyn M; Unit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium; Laboratory for Cell Biology and Histology, University of Antwerp, Antwerp, Belgium., Syrjänen S; Department of Oral Pathology and Oral Radiology, Institute of Dentistry and Medicine Research Laboratory, University of Turku, Turku, Finland.

Publikováno v: Vaccine [Vaccine] 2013 Dec 31; Vol. 31 Suppl 7, pp. H59-70.

Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.

Autor: Rogovskaya SI; Department of Obstetrics and Gynecology, Russian Medical Academy of Post-graduate Education, Moscow, Russia. Electronic address: srogovskaya@mail.ru., Shabalova IP; Department of Clinical Laboratory Diagnostics, Russian Medical Academy of Post-graduate Education, Moscow, Russia., Mikheeva IV; Department of Epidemiology, IM Sechenova Moscow Medical University, Moscow, Russia., Minkina GN; Department of Obstetrics and Gynecology, Moscow Medical University, Moscow, Russia., Podzolkova NM; Department of Obstetrics and Gynecology, Russian Medical Academy of Post-graduate Education, Moscow, Russia., Shipulina OY; Laboratory PCR Department, Central Institute of Epidemiology, Moscow, Russia., Sultanov SN; Research Centre of Obstetrics and Gynecology of Ministry of Health, Tashkent, Uzbekistan., Kosenko IA; Department of Oncogynecology, Research Centre of Oncology of Ministry of Health, Minsk, Belarus., Brotons M; Institut d'Investigació Biomèdica de Bellvitge - Bellvitge Biomedical Research Institute (IDIBELL), Unit of Infections and Cancer (UNIC), Cancer Epidemiology Research Program (CERP), Institut Català d'Oncologia - Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain., Buttmann N; Centre for Cancer Registry Data, Robert Koch-Institute, Berlin, Germany., Dartell M; Department of International Health, University of Copenhagen, Copenhagen, Denmark., Arbyn M; Unit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium; Laboratory for Cell Biology and Histology, University of Antwerp, Antwerp, Belgium., Syrjänen S; Department of Oral Pathology and Oral Radiology, Institute of Dentistry and Medicine Research Laboratory, University of Turku, Turku, Finland., Poljak M; Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

Publikováno v: Vaccine [Vaccine] 2013 Dec 31; Vol. 31 Suppl 7, pp. H46-58.